The UK has watched hemp-derived products move from niche health shops into supermarkets and pharmacies, and cannabidiol now appears in oils, gummies, capsules, and vaping devices alike. This spread has pulled several regulators into the same discussion at once, since food safety, medicines law, and device standards each cover a different slice of the same market. Retailers, importers, and everyday buyers must therefore satisfy a layered set of requirements, and each layer answers a different part of the legality question.
CBD’s Standing Under UK Law
Cannabidiol on its own carries no controlled-drug status in the UK, provided it stays within set limits for tetrahydrocannabinol and other cannabinoids. The Misuse of Drugs Act 1971 governs THC, and any preparation exceeding one milligram of THC, THCV, or CBN pulls the whole product into controlled-substance territory, regardless of what else it contains.
Manufacturers and importers rely on this threshold to source hemp strains and extraction methods that keep finished goods compliant, and lab-verified certificates of analysis have become the standard proof buyers ask for before purchase.
Where Novel Food Rules Apply
Food Standards Agency oversight covers CBD intended for ingestion, and this novel food framework has shaped the supplement side of the market since 2020. Businesses selling CBD oils, capsules, and edibles must link their products to a validated authorisation application, and the FSA maintains a public list of items permitted to stay on sale while assessment continues.
Three specific product applications moved through public consultation in the second half of 2025, marking the closest step yet toward full novel food authorisations for named CBD foods, and the outcome will determine which formulations can remain on shelves once the transitional list closes.
This framework, however, targets oral consumption, so it does not extend to inhaled formats such as vape liquids, balms, or cosmetics, and the FSA has also published direct guidance on CBD intake for consumers weighing daily amounts against emerging safety advice.
MHRA Oversight and CBD Vape Products
Because novel food rules stop at the point of ingestion, a separate regulatory layer governs anything inhaled, and this is where the Medicines and Healthcare products Regulatory Agency steps in alongside existing tobacco and vaping law.
A CBD vape sits at the intersection of three frameworks at once, since device hardware, cannabinoid content, and any health-related claims each answer to a different authority. The result is a compliance checklist that looks different from anything a CBD oil or gummy has to satisfy, and three areas carry the most weight for anyone assessing a product’s legitimacy.
Device and Nicotine Standards
The Tobacco and Related Products Regulations 2016 set hardware limits that apply to vaping devices in general, and these cover tank capacity, nicotine concentration where relevant, and packaging requirements. A compliant device caps tank or pod volume at 2ml, and if nicotine is present alongside the CBD, strength cannot exceed 20mg/ml. Manufacturers must also notify the MHRA before a product reaches market, and this notification step applies whether or not nicotine features in the formulation.
THC and Controlled Substance Limits
Vape liquids fall under the same Misuse of Drugs Act ceiling as other CBD goods, so any cartridge or liquid carrying more than trace THC becomes an unlawful controlled substance rather than a wellness product. Buyers checking a certificate of analysis for a CBD vape kit UK retailers list should look specifically for cannabinoid breakdowns that confirm THC content is below that legal line.
Medicinal Claims and Licensing
Products cannot promise to treat, diagnose, or cure any condition unless they carry a medicines licence from the MHRA, and Epidyolex remains the only CBD-based product to hold that status in the UK, prescribed for specific seizure conditions. General retail CBD vapes and supplements must therefore market themselves on lifestyle or wellness terms alone, and any packaging implying therapeutic outcomes risks enforcement action.
Choosing a Compliant Vape Kit
Given these overlapping rules, buyers looking at CBD vape options benefit from checking a few consistent markers before purchase, and reputable UK retailers now display this information as standard. An MHRA notification reference, a recent certificate of analysis, and clear THC figures together confirm a product meets current requirements, and their absence is usually the clearest warning sign.
Established retailers stocking CBD vape ranges typically list these details alongside flavour and strength options, which gives buyers a faster route to a compliant choice than searching through separate regulator databases. Brands built around UK-made premium CBD products tend to publish this documentation directly on their product pages, which shortens the verification process considerably.
Looking Ahead
The FSA’s novel food consultation outcome and the wider rollout of vaping legislation through 2026 are likely to narrow the current list of compliant CBD products further, rather than expand it. For an industry that grew quickly with limited oversight, that narrowing points toward a market where fewer products remain on sale, but each one carries clearer proof of what it contains and how it was assessed.
